EGFR and neoplasm: U251-MG xenografts transfected with Tat/BM/PAMAM-psiRNA-EGFR demonstrated a decrease in tumor volume, and immunohistopathological studies of protein expression in situ matched the in vitro results (Han et al., 2010).